Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Oleoylethanolamide
Cat. No.:
0225LY-0815
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Oleoylethanolamide is a high-affinity endogenous agonist that naturally targets PPAR-alpha.
Synonym:
N-Oleoylethanolamide;Oleamide MEA;Oleic acid monoethanolamide; 111-58-0; N-(2-Hydroxyethyl)oleamide; Oleylethanolamide; Oleamide MEA; N-oleoyl ethanolamine; Oleoyl Ethanolamide; Oleoyl monoethanolamide; (Z)-N-(2-hydroxyethyl)octadec-9-enamide; N-(2-Hydroxyethyl)-9-octadecenamide; N-(Hydroxyethyl)oleamide; OEA; Oleic acid ethanolamide; N-(9Z-octadecenoyl)-ethanolamine; (9Z)-N-(2-hydroxyethyl)octadec-9-enamide; N-(cis-9-octadecenoyl) ethanolamine; N-(hydroxyethyl) oleamide; 9-Octadecenamide, N-(2-hydroxyethyl)-
CAS No.:
111-58-0
Compound CID:
5283454
Formula:
C20H39NO2
Formula Weight:
325.53
Specification
Relative Density:
0.915 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Oleoylethanolamide can be used in lipid metabolism studies to explore the regulation of satiety and body weight through PPAR alpha activation.
Library Information
Target:
PPAR
Receptor:
PPARα
Pathways:
DNA damage/DNA repair; Metabolism; Nuclear receptor signaling
Plate Number:
AOCL-11
Plate Location:
e4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
250 mg/mL; 767.98 mM
Water Max Solubility:
<0.1 mg/mL (insoluble)





